FHL2 Antikörper
-
- Target Alle FHL2 Antikörper anzeigen
- FHL2 (Four and A Half LIM Domains 2 (FHL2))
-
Reaktivität
- Human, Maus, Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser FHL2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunofluorescence (Cultured Cells) (IF (cc))
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Purified by Protein A.
- Immunogen
- Recombinant protein within C-terminal human FHL2.
- Klon
- 2A4
- Isotyp
- IgG
- Top Product
- Discover our top product FHL2 Primärantikörper
-
anti-Four and A Half LIM Domains 2 (FHL2) (AA 1-279) antibody
FHL2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) antibodyFHL2 Reaktivität: Human, Maus, Ratte WB, ELISA, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (AA 1-279) antibodyFHL2 Reaktivität: Human WB, ELISA, IF Wirt: Maus Monoclonal 2G3-1A5 unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (AA 112-233) antibodyFHL2 Reaktivität: Human ELISA, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (AA 199-248) antibodyFHL2 Reaktivität: Human, Maus, Ratte, Hund, Pferd, Zebrafisch (Danio rerio), Affe, Fledermaus, Hamster, Huhn WB, IHC, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (C-Term) antibodyFHL2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Zebrafisch (Danio rerio) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (C-Term) antibodyFHL2 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Hund, Pferd, Kaninchen, Meerschweinchen, Zebrafisch (Danio rerio) WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) antibodyFHL2 Reaktivität: Human, Maus WB, IHC (p), IP Wirt: Maus Monoclonal 31-10-34 unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (C-Term) antibodyVerified FHL2 Reaktivität: Human, Maus WB, ELISA Wirt: Ziege Polyclonal unconjugated
anti-Four and A Half LIM Domains 2 (FHL2) (AA 182-231) antibodyFHL2 Reaktivität: Human, Rind (Kuh), Meerschweinchen, Affe WB Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IF(ICC) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 1xTBS ( pH 7.4), 1 % BSA, 40 %Glycerol and 0.05 % Sodium Azide.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for up to 2 weeks. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- FHL2 (Four and A Half LIM Domains 2 (FHL2))
- Andere Bezeichnung
- FHL2 (FHL2 Produkte)
- Synonyme
- AAG11 antikoerper, DRAL antikoerper, FHL-2 antikoerper, SLIM-3 antikoerper, SLIM3 antikoerper, C76204 antikoerper, FHL2 antikoerper, zgc:92428 antikoerper, zgc:103466 antikoerper, four and a half LIM domains 2 antikoerper, four and a half LIM domains 2a antikoerper, four and a half LIM domains 2b antikoerper, FHL2 antikoerper, Fhl2 antikoerper, fhl2 antikoerper, fhl2a antikoerper, fhl2b antikoerper
- Hintergrund
-
Synonyms: Four and a half LIM domains protein 2, LIM domain protein DRAL, Skeletal muscle LIM-protein 3, FHL-2, SLIM-3, DRAL, SLIM3
Background: May function as a molecular transmitter linking various signaling pathways to transcriptional regulation. Negatively regulates the transcriptional repressor E4F1 and may function in cell growth. Inhibits the transcriptional activity of FOXO1 and its apoptotic function by enhancing the interaction of FOXO1 with SIRT1 and FOXO1 deacetylation. Negatively regulates the calcineurin/NFAT signaling pathway in cardiomyocytes.
- Gen-ID
- 2274
- UniProt
- Q14192
- Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Lipid Metabolism by PPARalpha
-
